Self-Reported Use of Pharmaceuticals Among Patients With Irritable Bowel Syndrome in Primary Care

BACKGROUND: Irritable bowel syndrome (IBS) has an estimated 10%-12% prevalence in industrial countries. Studies from the United States have shown that IBS causes notable financial losses for employers. Due to the lack of pathophysiological markers, only a fraction of the pharmacological management o...

Descripción completa

Detalles Bibliográficos
Autores principales: Faresjo, Ashild, Grodzinsky, Ewa, Johansson, Saga, Wallander, Mari-Ann, Faresjo, Tomas, Timpka, Toomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438291/
https://www.ncbi.nlm.nih.gov/pubmed/19006443
http://dx.doi.org/10.18553/jmcp.2008.14.9.870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438291/
https://www.ncbi.nlm.nih.gov/pubmed/19006443
http://dx.doi.org/10.18553/jmcp.2008.14.9.870

Ejemplares similares